GEEVO吉沃科技分体式蝶阀密闭转移技术助力医药行业
近年来，随着中国相关法律的完善，药企对制药工艺的要求逐步提高。当下新兴生物技术的发展势头迅猛，比如基因编辑技术、新一代测序技术、生物制品一次性生产工艺，粉体物料的密闭转移技术等。这些技术不仅促进了基础医学领域的飞速发展，也给生物制药企业带来新风，在很大程度上改变了整个医药行业的发展方向。
在新型生物的研发与生产的背后，一些基本的生物技术与仪器设备必不可少，如细胞的处理与培养、生物样本的提取制备、高致敏性及无菌物料的密闭转移等技术及相关仪器。可以说，正是这些技术与仪器设备的发展，才带动了新型生物在医学上的应用。现在的生物制药企业已经不需要花太多精力在一般的生产工艺上。在蛋白质药物生产的产业链上，设备供应商的位置不可或缺，尤其是在分体式蝶阀密闭转移技术已经逐渐应用于生物制药行业的今天。
GEEVOSBV系列分体式蝶阀密闭转移技术之所以被生物制药企业广泛应用，在于其能确保高致敏性或无菌物料可以快速进行密闭转移操作，且其在线功能（CIP在线清洗 和 SIP在线灭菌）使其在不需拆卸与重新装配设备及管路，就可以对设备及管路进行有效的清洗，将上批生产或实验在设备及管路中的残留物减少到不会影响下批产物质量和安全性的程度。
同时，吉沃多种规格及将逐步完善的配套转移料桶与输送袋，来应对各种配套设备以及多变的市场需求。而且，GEEVOSBV系列分体式蝶阀的投资成本低于传统设备的成本，它能够保持较高的市场化速度，在较短的时间内完成厂房建设、验证到批次更换等项目。在保证药物安全性与有效性的基础上，给予客户优化的工艺方案。
2015年中国蛋白药质量与技术创新研讨会日前于美丽的富春江畔成功召开。聚集来自生物医药、临床医保、科技外贸、法规部门等相关领域顶尖专家，探讨最新药品评审审批与医保制度改革对产业的影响、产业在质量安全标准、产品国际注册和企业国际化的发展，以及肿瘤生物治疗等生物制药关键技术、产业平台及供应链等。吉沃科技通过自主创新为客户高端研究和药物研发带来变革，确保客户在实验室工作及研究中取得成功。
GEEVO's new biotechnologies promote the development of the pharmaceutical industry
In recent years, emerging biotechnologies covering areas as diverse as gene editing, next-generation genetic sequencing, disposable biological products, and powder containment transfer technology, have not only driven the rapid development of preclinical medicine, they have also created huge business opportunities for pharmaceutical companies, transforming the entire industry landscape.
A number of key biotechnologies and specialized equipment are essential to the development and production of these new bio industries, such as cell processing and cultivation, protein analysis, preparation of biological samples, and sensitization or sterile material containment transfer. The development of these technologies and instruments is critical to the creation of new biological and clinical applications. At present, biopharmaceutical companies do not need to invest too much energy on general production processes. Especially in the present industry environment, where split butterfly valve are being widely used in the biopharmaceutical industry.
The reason why GEEVOSBV series split butterfly valve use widely is it can transfer sensitization or sterile material containment and fast, and its CIP and SIP function, make it clean or sterilize equipment and pipe without disassemble, reduce its possible residue of last batch of products, keep its safely operation for the following batches.
GEEVOSBV series split butterfly valve are widely applied by biopharmaceutical companies, and are valued for their flexibility. They are capable of producing different types, and being improved matched barrel/bag, making them suitable for developing treatments for a variety of demand, as well as responding to changeable market demands. Moreover, the investment cost of GEEVOSBV series split butterfly valve is far less than the cost of the larger traditional equipments, and they also shorten the cycle of plant construction, verification and batch replacement.
On Oct.2015, GEEVO Company attended the Biomedicine China：Quality & Innovation 2015 (II) which held near the beautiful Fuchun river. Gathered professional experts from biological medicine, clinical health care, science and technology, regulations, foreign trade department and other related fields. Discussed new drug approval and the health care system reform's influence on the industry, industry standard in quality and safety, the international registration of the products and the development of internationalization, and tumor biological treatment such as biological pharmaceutical platform and key technology, industry supply chain, etc. GEEVO devotes himself to bring customers’ sucess in laboratory work and research, through independent innovation of science and technology.